The second edition of Elets Diagnostics Leadership Summit will create a virtual networking-cum-knowledge platform to explore adoption of newage technologies and best practices, investment opportunities, and evaluate policies for transforming the diagnostics industry.
The Indian diagnostics industry emerged as the backbone of the Covid-19 management. It will gain more prominence in the light of greater realisation to prepare for the possible third wave of the Covid-19 and future pandemics. Elets Technomedia Pvt Ltd along with its flagship eHEALTH is set to organise the second edition of the Elets Diagnostics Leadership Summit on 23 – 24 September 2021 on a Virtual 3D platform – Avtaar
With the theme, ‘Creating a Future Ready Diagnostics Sector’, the two-day Summit will be a virtual n et wo r k i n g – c u m – k n ow l e d g e platform to deliberate on digital technologies and innovations, investment opportunities, latest government policies and schemes, and best practices for transforming the diagnostics industry.
This Summit will be held after successfully organising the first edition of the Elets Diagnostics Leadership Summit on February 19 – 20 2021 virtually, which witnessed over 500 delegates, more than 70 speakers and 12 thought-provoking sessions and panel discussions.
Participants for the second edition of Elets Diagnostics Leadership Summit will be Policy Makers from Government Departments; MDs, CEOs, Promoters of Diagnostic Centre (Single Centre & Multiple Chain); MDs & CEOs of Genomics Test Labs; HoDs of Clinical Laboratories of Hospitals; Scientists, Technician & Technologists of Labs; Technology Providers; and Academicians.
Scientific Advisory Committee Member for the Summit are (Honorary) Brig Dr Arvind Lal Executive Chairman, Dr Lal PathLabs Ltd has joined the committee. Also, Dr Ravi Gaur, Principal Advisor Spice Health (Spice Jet Promoters Venture) and Founder, Dr G Path Labs, CoChair, CII Delhi Chapter Health Committee; Dr Avinash Phadke, Founder, SRL Phadke Labs; and N Venkateswaran, CEO, National Accreditation Board for Testing and Calibration Laboratories (NABL) are in the committee.
Joining as the Corporate Speakers are Dr Debkishore Gupta, Director, Medical Affairs, Cepheid; Dr Li Yanfeng, Head of Business Development (IVD), GenScript Asia Pacific; Suresh Vazirani, Founder Chairman, Transasia-Erba International Group of Companies; Dr Manoj Chugh, Vice President, R&D (Reagents), Transasia Bio-Medicals Ltd; Rajasa Jialdasani, Medical Director, Qritive Pte Ltd; Niraj Desai, VP, Sales (Enterprise), CrelioHealth; Nitin Nayyar, Product & Marketing Operations, Nihon Kohden India; and Rahul Chaudhary, National Manager – IVD Business, Nihon Kohden.
Plus, the Key Speakers are Dr Ambarish Padhee, Director, Central Laboratory, Kalinga Institute of Medical Sciences, KIIT University; Indranil Roy Choudhry, Group COO, Apex Kidney Care; Dr Disha Bhatia, Head of Department Microbiology, CORE Diagnostics; Dr Anjali Bhutani, Director & Head, the Department of Lab Medicine, Max Super Speciality Hospital, Mohali; Dr Shelly Mahajan, Lab Director & Clinical Lead, Genomics, CARINGdx, Mahajan Imaging, and Lab Director & Pathologist, Mahajan Diagnostics; Dr Rohit Chawla, Professor, the Department of Microbiology, Maulana Azad Medical College; Dr Neeraj Jain, Founder President, MELAP; Dr Sanjay Ingle, Chief, Lab Services, Metropolis Healthcare; Dr Jayalakshmi Jayarajan, Professor & HoD, KMCH Institute of Health Sciences & Research; Dr Aruna Poojary, HoD, the Department of Pathology & Microbiology, and Sr Consultant Microbiologist & Incharge, Infection Control, Breach Candy Hospital; Dr Dilip Kumar, Associate Director & Manager Quality, Maxlab, Max Super Speciality Hospital, Saket, New Delhi; Dr Shanta Dutta, Scientist G and Director, ICMR – National Institute of Cholera and Enteric Diseases; Dr Kawaljeet Kaur, Lab Head & MR Quality Assurance, SRL Ltd, Fortis Escort Ltd; and Dr Abhik Banerjee, Zonal Technical Chief, East Zone, Apollo Diagnostics.
Anand K, Chief Executive Officer, SRL Diagnostics; Dr Amar Dasgupta, Director, Medical Services, Suburban Diagnostics; Dr Ajay Phadke, Head, SRL Dr Avinash Phadke Labs; Dr Namita Jaggi, Chairperson, Lab Services & Infection Control, and Chief- Education & Research, Artemis Hospitals; Dr Anuradha Udumudi, Founder Director, Genetech Pvt Ltd; Dr Smita Hiras Sudke, Lab Director, Global Reference Lab & Zonal Technical Chief, Telangana Apollo Diagnostics; Dr Seema Kochhar, Principal Director, Quality Management & Excellence, Dr Lal PathLabs Pvt Ltd; Dr Hariom Sharma, Professor & Lab Head, Sir T Hospital; Dr Sanjay Arora, MD and Founder, Suburban Diagnostics; Dr Anupa Dixit, Lab Director, Suburban Diagnostics; and Dr Ameeta Joshi, Professor & Head Microbiology, Grant Medical College, J J Hospital. Dr Arjun Dang, CEO, Dr Dang’s Lab; Dr Srinivas Chakravarthy N, Vice President, Technical HLA, TI Lab and Head, Laboratory, SRL Diagnostics and Fortis Hospital; Dr Barnali Das, Consultant Laboratory Medicine, Kokilaben Dhirubhai Ambani Hospital, Executive Member, IFCC Scientific Division, Chair, AACC India Section, CAP Inspector, and NABL Assessor; Group Captain (Retd) Dr (Prof ) Renu Madan, HoD, Pathology and Lab Medicine, Venkateshwar Hospital; Sanjeev Vashishta, Managing Director & CEO, PathKind Diagnostics Pvt Ltd; Prof Ashok Rattan, Advisor, Pathkind Laboratories; Dr Maithili Kavathekar, Director Laboratory Services, Sahyadri Speciality Hospital; Dr Anjali Tiwari, Lab Director and Technical Manager, Regency Hospital Ltd, Kanpur; Sukrut Jobanputra, CEO & Executive Director, Labassure; Dr Anita S. Bhaduri, President, IAPIndian Division, Histopathologist & HoD, Lab Medicine, PD Hinduja Hospital & MRC; Dr (Col) Jyoti Kotwal, Senior Consultant & Head, Department of Haematology, Sir Ganga Ram Hospital; Dr Vineeta Sood, Lab Director, Department of Lab Medicine, Alchemist Hospital; Dr Rinu Goyal, Consultant Pathologist & Head, Laboratory, Sitaram Bhartia Institute of Science and Research; Dr Sunita Deshmukh, HoD, Lab Sciences & Blood Bank, Paras Hospitals; Dr Varsha Vadera, Consultant and Head Laboratory Medicine & Advanced Diagnostics, Kokilaben Dhirubhai Ambani Hospital; Dr Anil Handoo, Senior Director Hospital Laboratory Services, BLK Super Speciality Hospital; Dr Amrit Kaur Kaler, Professor of Pathology, TOMCH, Fellow (Molecular pathology & Cancer Genomics), Strand Life Sciences, HCG Bangalore; Dr (Col) Prabal Deb, Head of Operations (India), Aster Labs, and Lab Director, Aster Reference Lab, Bengaluru.
The second edition of Elets Diagnostics Leadership Summit will bring together the Indian diagnostics community and discuss varied pertinent issues, including: How IVD Industry transformed during the Covid-19 Pandemic: Scope & Challenges; How the diagnostic segment is gearing up for the possible third wave of the Covid-19 pandemic; The state of the Indian diagnostics industry: Outlook, Investment Scenario and Growth Opportunities; Diagnostics 4.0: The future of diagnostics labs in the digital era; Advanced Diagnostics for Infectious Disease: New testing platforms, technologies, and solutions; Diagnostics tools in Telehealth during the pandemic; Harmonising quality, cost and regulations for proliferating essential diagnostics during the pandemic; Role of lab automation in improving diagnostics operations; Robotisation in clinical diagnostics: Enabling personalised medicine and patientcentric approach; How Automation is Bringing Rapid Advances in Genomics; and Clinical Significance of CBC + ESR in Chronic Disease Patient Care Management: What Experts Suggest?
Partners for the second edition of the Elets Diagnostics Leadership Summit 2021 are
Cepheid (Platinum Partner), Nihon Kohden India (Scientific Partner), and Premas Life Sciences (Gold Partner), Transasia (IVD Partner), CrelioHealth (Partner) and Qritive (Partner)